-
公开(公告)号：US08431613B2
公开(公告)日：2013-04-30
申请号：US13459959
申请日：2012-04-30
申请人： Koichi Shudo , Hiroyuki Kagechika
发明人： Koichi Shudo , Hiroyuki Kagechika
IPC分类号： A01N37/00 , A01N55/00 , A61K31/185 , A61K31/695
CPC分类号： A61K31/192 , A61K31/695
摘要： A medicament for promoting memory consolidation, which comprises, as an active ingredient, a non-natural retinoid, preferably a retinoid having a basic skeleton comprising an aromatic ring bound with an aromatic carboxylic acid or tropolone by means of a bridging group, more preferably 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid or 4-[(3,5-bis-trimethylsilylphenyl)-carboxamido]benzoic acid.
摘要翻译： 一种用于促进记忆巩固的药物，其包含作为活性成分的非天然类视黄醇，优选具有基本骨架的类视黄醇，所述基本骨架包含通过桥连基团与芳族羧酸或托洛替林结合的芳环，更优选4 - [（5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸或4 - [（3,5-双三甲基甲硅烷基苯基） - 甲酰胺基]苯甲酸。
-
公开(公告)号：US20090253796A1
公开(公告)日：2009-10-08
申请号：US12412678
申请日：2009-03-27
IPC分类号： A61K31/196 , A61P9/10
CPC分类号： A61K31/27 , A61K31/695 , A61L31/16
摘要： A medicament for prophylactic and/or therapeutic treatment of a vascular disease such as vascular restenosis and/or reocclusion after percutaneous transluminal coronary angioplasty using an intravascular stent, which comprises as an active ingredient a substance selected from the group consisting of retinoids and agents for controlling actions of retinoids such as 4-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid or a salt thereof, or 4-[[[3,5-bis-(trimethylsilyl)phenyl]carbonyl]amino]benzoic acid or a salt thereof, wherein said substance has substantially no antiproliferative action on vascular endothelial cells, but substantially has antiproliferative action on vascular smooth muscle cells.
摘要翻译： 用于使用血管内支架的经皮腔内冠状动脉成形术之后的血管疾病如血管再狭窄和/或再闭塞的预防和/或治疗性治疗药物，其包含选自维甲酸类和控制剂的活性成分 类维生素如4- [5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸或其盐或4 - [[[3,5- - 双（三甲基甲硅烷基）苯基]羰基]氨基]苯甲酸或其盐，其中所述物质对血管内皮细胞基本上没有抗增殖作用，但对血管平滑肌细胞基本具有抗增殖作用。
-
公开(公告)号：US08198329B2
公开(公告)日：2012-06-12
申请号：US10598709
申请日：2005-03-09
申请人： Koichi Shudo , Hiroyuki Kagechika
发明人： Koichi Shudo , Hiroyuki Kagechika
CPC分类号： A61K31/192 , A61K31/695
摘要： A medicament for promoting memory consolidation, which comprises, as an active ingredient, a non-natural retinoid, preferably a retinoid having a basic skeleton comprising an aromatic ring bound with an aromatic carboxylic acid or tropolone by means of a bridging group, more preferably 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid or 4-[(3,5-bis-trimethylsilylphenyl)-carboxamido]benzoic acid.
摘要翻译： 一种用于促进记忆巩固的药物，其包含作为活性成分的非天然类视黄醇，优选具有基本骨架的类视黄醇，所述基本骨架包含通过桥连基团与芳族羧酸或托洛替林结合的芳环，更优选4 - [（5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸或4 - [（3,5-双三甲基甲硅烷基苯基） - 甲酰胺基]苯甲酸。
-
公开(公告)号：US20080255069A1
公开(公告)日：2008-10-16
申请号：US12065099
申请日：2006-09-07
申请人： Koichi Shudo , Hiroyuki Kagechika , Hiroshi Fukasawa , Tetsuro Matsuishi , Naoko Katsumura , Miwako Ishido
发明人： Koichi Shudo , Hiroyuki Kagechika , Hiroshi Fukasawa , Tetsuro Matsuishi , Naoko Katsumura , Miwako Ishido
IPC分类号： A61K31/695 , A61K31/27
CPC分类号： A61K31/192
摘要： A medicament for preventive and/or therapeutic treatment of a bowel diseases such as inflammatory bowel diseases including Crohn's disease, which comprises as an active ingredient a retinoid such as, for example, 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid.
摘要翻译： 一种用于预防和/或治疗诸如包括克罗恩病在内的肠疾病的肠疾病的药物，其包含类视黄醇作为活性成分，例如4 - [（5,6,7,8-四氢 - 5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸。
-
公开(公告)号：US08105833B2
公开(公告)日：2012-01-31
申请号：US12535576
申请日：2009-08-04
CPC分类号： C12N5/0062 , C12N2501/385 , C12N2501/999 , C12N2506/00
摘要： A method for forming an organ and/or tissue from undifferentiated cells derived from a vertebrate animal in vitro, which comprises the step of culturing the undifferentiated cells derived from a vertebrate animal in the presence of a retinoic acid X receptor ligand (e.g., a retinoic acid X receptor agonist or antagonist), and a method for forming a pancreas from undifferentiated cells derived from a vertebrate animal in vitro or a method for forming a tissue having morphology and function of a pancreas from undifferentiated cells derived from a vertebrate in vitro, which comprises the step of culturing the undifferentiated cells derived from a vertebrate animal in the presence of a retinoic acid receptor ligand, together with activin, that does not substantially bind to the retinoic acid receptor subtype γ.
摘要翻译： 一种用于从体外衍生自脊椎动物的未分化细胞形成器官和/或组织的方法，其包括在视黄酸X受体配体（例如视黄酸）存在下培养源自脊椎动物的未分化细胞的步骤 酸X受体激动剂或拮抗剂）以及从体外衍生自脊椎动物的未分化细胞形成胰腺的方法或用于从体外衍生自脊椎动物的未分化细胞形成具有胰腺形态和功能的组织的方法，其中 包括在视黄酸受体配体存在下培养源自脊椎动物的未分化细胞与活化素一起基本上不结合视黄酸受体亚型γ的步骤。
-
公开(公告)号：US20080021108A1
公开(公告)日：2008-01-24
申请号：US10598709
申请日：2005-03-09
申请人： Koichi Shudo , Hiroyuki Kagechika
发明人： Koichi Shudo , Hiroyuki Kagechika
IPC分类号： A61K31/192 , A61K31/07 , A61P25/16 , A61P25/28
CPC分类号： A61K31/192 , A61K31/695
摘要： A medicament for promoting memory consolidation, which comprises, as an active ingredient, a non-natural retinoid, preferably a retinoid having a basic skeleton comprising an aromatic ring bound with an aromatic carboxylic acid or tropolone by means of a bridging group, more preferably 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthaleny)carbamoyl]benzoic acid or 4- [(3,5-bis-trimethylsilylphenyl)-carboxamido]benzoic acid.
摘要翻译： 一种用于促进记忆巩固的药物，其包含作为活性成分的非天然类视黄醇，优选具有基本骨架的类视黄醇，所述基本骨架包含通过桥连基团与芳族羧酸或托洛替林结合的芳环，更优选4 - [（5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸或4 - [（3,5-双三甲基甲硅烷基苯基） - 甲酰胺基]苯甲酸。
-
公开(公告)号：US20070049579A1
公开(公告)日：2007-03-01
申请号：US11366454
申请日：2006-03-03
申请人： Ryozo Nagai , Ichiro Manabe , Takayuki Shindo , Hiroshi Iwata , Koichi Shudo , Hiroyuki Kagechika
发明人： Ryozo Nagai , Ichiro Manabe , Takayuki Shindo , Hiroshi Iwata , Koichi Shudo , Hiroyuki Kagechika
IPC分类号： A61K31/551
CPC分类号： A61K31/551
摘要： A medicament having a neovascularization promoting action, which comprises a retinoid antagonist such as 4-(5H-7,8,9,10-tetrahydro-5,7,7,10,10-pentamethylbenzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)benzoic acid as an active ingredient and is useful for prophylactic and/or therapeutic treatment of ischemic diseases and wounds.
摘要翻译： 具有新血管形成促进作用的药物，其包含类视黄醇拮抗剂，例如4-（5H-7,8,9,10-四氢-5,7,7,10,10-五甲基苯并[e]萘并[2,3- b] [1,4]二氮杂萘-13-基）苯甲酸作为活性成分，可用于预防和/或治疗缺血性疾病和伤口。
-
公开(公告)号：US20050234130A1
公开(公告)日：2005-10-20
申请号：US10511274
申请日：2003-04-22
IPC分类号： A61K31/27 , A61K31/695 , A61L31/16 , A61P9/00 , A61P9/10 , A61P9/14 , A61P43/00 , A61K31/195 , A61K31/203
CPC分类号： A61K31/27 , A61K31/695 , A61L31/16
摘要： A medicament for prophylactic and/or therapeutic treatment of a vascular disease such as vascular restenosis and/or reocclusion after percutaneous transluminal coronary angioplasty using an intravascular stent, which comprises as an active ingredient a substance selected from the group consisting of retinoids and agents for controlling actions of retinoids such as 4-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid or a salt thereof, or 4-[[[(3,5-bis-(trimethylsilyl)phenyl]carbonyl]amino]benzoic acid or a salt thereof, wherein said substance has substantially no antiproliferative action on vascular endothelial cells, but substantially has antiproliferative action on vascular smooth muscle cells.
摘要翻译： 用于使用血管内支架的经皮腔内冠状动脉成形术之后的血管疾病如血管再狭窄和/或再闭塞的预防和/或治疗性治疗药物，其包含选自维甲酸类和控制剂的活性成分 类维生素如4- [5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸或其盐或4 - [[[（3,3- （三甲基甲硅烷基）苯基]羰基]氨基]苯甲酸或其盐，其中所述物质对血管内皮细胞基本上没有抗增殖作用，但对血管平滑肌细胞基本具有抗增殖作用。
-
公开(公告)号：US08168677B2
公开(公告)日：2012-05-01
申请号：US12559268
申请日：2009-09-14
申请人： Koichi Shudo , Hiroyuki Kagechika , Hiroshi Fukasawa , Tetsuro Matsuishi , Naoko Katsumura , Miwako Ishido
发明人： Koichi Shudo , Hiroyuki Kagechika , Hiroshi Fukasawa , Tetsuro Matsuishi , Naoko Katsumura , Miwako Ishido
IPC分类号： A61K31/192 , A61K31/554 , A61K31/5513 , A61K31/695
CPC分类号： A61K31/192
摘要： Method for therapeutic treatment of inflammatory bowel disease, including Crohn's disease, comprising administering to a patient in need thereof a therapeutically effective amount of a composition comprising a retinoid as an active ingredient to treat the inflammatory bowel disease, the retinoid being selected from the group consisting of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid, 4-[(3,5-bis-trimethylsilylphenyl)carboxamido]benzoic acid, 4-[2,3-(2,5-dimethyl-2,5-hexano)dibenzo[b,f][1,4]thiazepin-11-yl]benzoic acid, and 4-(5H-7,8,9,10-tetrahydro-5,7,7,10,10-pentamethylbenzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)benzoic acid.
摘要翻译： 包括克罗恩病在内的治疗性治疗炎症性肠病的方法，包括向有需要的患者施用治疗有效量的包含类视黄醇作为活性成分以治疗炎性肠病的组合物，所述类视色素选自 的4 - [（5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸，4 - [（3,5-双三甲基甲硅烷基苯基）甲酰氨基]苯甲酸 ，4- [2,3-（2,5-二甲基-2,5-己烷）二苯并[b，f] [1,4]硫杂吖庚因-11-基]苯甲酸和4-（5H- ，9,10-四氢-5,7,7,10,10-五甲基苯并[e]萘并[2,3-b] [1,4]二氮杂-13-基）苯甲酸。
-
公开(公告)号：US08071647B2
公开(公告)日：2011-12-06
申请号：US12872171
申请日：2010-08-31
申请人： Koichi Shudo , Hiroyuki Kagechika , Hiroshi Fukasawa , Tetsuro Matsuishi , Naoko Katsumura , Miwako Ishido
发明人： Koichi Shudo , Hiroyuki Kagechika , Hiroshi Fukasawa , Tetsuro Matsuishi , Naoko Katsumura , Miwako Ishido
IPC分类号： A61K31/196
CPC分类号： A61K31/192
摘要： Method for suppressing adhesion of the intestines or therapeutic treatment of adhesion of the intestines comprising administering to a patient in need thereof a therapeutically effective amount of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid. There is also provided a medicament for suppressing adhesion of the intestines and/or therapeutic treatment of bowel diseases such as inflammatory bowel diseases, including Crohn's disease, which comprises as an active ingredient a retinoid such as, for example, 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid.
摘要翻译： 用于抑制肠粘连的方法或肠道粘连的治疗处理方法，包括向有需要的患者施用治疗有效量的4 - [（5,6,7,8-四氢-5,5,8,8-四氢 - 四甲基-2-萘基）氨基甲酰基]苯甲酸。 还提供了一种用于抑制肠粘连和/或诸如包括克罗恩病在内的肠疾病的肠道疾病的治疗性治疗的药物，其包含类视黄醇作为活性成分，例如4 - [（5， 6,7,8-四氢-5,5,8,8-四甲基-2-萘基）氨基甲酰基]苯甲酸。
-
-
-
-
-
-
-
-
-
搜索结果
73 条记录 (耗时 0.018 秒)
